Global Anticancer Drugs Market Growth (Status and Outlook) 2024-2030

Global Anticancer Drugs Market Growth (Status and Outlook) 2024-2030

Anticancer drugs are medications used to treat cancer by targeting and killing cancer cells or inhibiting their growth. Anticancer drugs are medications specifically designed to combat cancer by either inhibiting the growth of cancer cells or inducing their death. These drugs operate through various mechanisms, such as disrupting the cell cycle, interfering with specific signaling pathways crucial for cancer cell survival, or targeting the blood vessels that support tumor growth. Anticancer drugs encompass a diverse range of classes, including cytotoxic drugs, targeted therapies, hormone therapies, immunotherapies, and angiogenesis inhibitors. The selection of these drugs depends on the type of cancer, its stage, and individual patient characteristics. While these medications play a crucial role in cancer treatment, they may also have side effects due to their impact on rapidly dividing normal cells.

The global Anticancer Drugs market size is projected to grow from US$ 201610 million in 2024 to US$ 391180 million in 2030; it is expected to grow at a CAGR of 11.7% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Anticancer Drugs Industry Forecast” looks at past sales and reviews total world Anticancer Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anticancer Drugs sales for 2023 through 2029. With Anticancer Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anticancer Drugs industry.

This Insight Report provides a comprehensive analysis of the global Anticancer Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anticancer Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anticancer Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anticancer Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anticancer Drugs.

Global key players of Anticancer Drugs include Merck & Co, Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, etc. The top five players hold a share over 55%. North America is the largest market, and has a share about 55%, followed by Asia-Pacific and Europe with share 21% and 19%, separately. In terms of product type, Targeted Therapy is the largest segment, occupied for a share of 58%. In terms of application, Blood-related Cancer has a share about 23 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Anticancer Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:
Cancer Immunotherapy
Targeted Therapy
Chemotherapy
Other

Segmentation by Application:
Lung Cancer
Breast Cancer
Prostate Cancer
Blood-related Cancer
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Cancer Immunotherapy
Targeted Therapy
Chemotherapy
Other

Segmentation by Application:
Lung Cancer
Breast Cancer
Prostate Cancer
Blood-related Cancer
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer
GSK
Exelixis
Regeneron
Innovent
Hengrui Medicine

Please note: The report will take approximately 2 business days to prepare and deliver.